| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2003-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7baebf8d43a81453019fed8a5db1725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e934d381c4666dfd13ca711fadb61584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b2b267fb68337fc600823e2d0a9d2b |
| publicationDate |
2004-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004138234-A1 |
| titleOfInvention |
Histamine receptor antagonists |
| abstract |
The present invention provides a combination of (a) a histamine H 1 receptor antagonist and (b) an antagonist that is at least 10-fold selective for the histamine H 4 receptor as compared to the histamine H 3 receptor; and an antagonist that is at least 10-fold selective for the histamine H 4 receptor as compared to the histamine H 3 receptor: and compositions and uses thereof. |
| priorityDate |
2001-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |